Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*
Structure of HCMV pp65 265-275 (HLA-B*07:02)
Logo for Infectious disease
Infectious disease

HCMV pp65 265-275 (HLA-B*07:02)

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart
Product number: EP07911_1

Description

RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

TechData

Sequence: RPHERNGFTVL
Gene: UL83
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: 65 kDa phosphoprotein
Species: Human cytomegalovirus (Human herpesvirus 5)
Allele: HLA-B*07:02
Application: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication: Infectious disease, Cancer, Neuroscience, Diabetes
Purity: 95% HPLC-MS

Documents

Material data sheet Safety data sheet Storage and handling of peptides Probing of membranes with HRP

More HCMV pp65 peptides
HCMV pp65 113-121 (HLA-A*24:02) ( VYALPLKML )
Antigen Peptide HCMV pp65 (113-121) HLA-A*24:02 (VYALPLKML) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VYALPLKML is a linear peptidic epitope (epitope ID 71976) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €105.00*
Details
HCMV pp65 123-131 (HLA-B*35:01) ( IPSINVHHY )
CMV-derived peptide of IPSINVHHY sequence covering 123-131 and B*35:01 molecule. IPSINVHHY is a linear peptidic epitope (epitope ID 28061) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €105.00*
Details
HCMV pp65 16-24 (HLA-A*11:01) ( GPISGHVLK )
HCMV pp65 (16-24) peptide GPISGHVLK (HLA-A*11:01) for stimulation of human CMV pp65 (16-24)-specific CD8+ T-cells.

From €105.00*
Details
HCMV pp65 265-275 (HLA-B*07:02) ( RPHERNGFTVL )
RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) ( QYDPVAALF )
HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) QYDPVAALF for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. QYDPVAALF is a linear peptidic epitope (epitope ID52886) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €105.00*
Details
HCMV pp65 363-373 (HLA-A*01:01) ( YSEHPTFTSQY )
YSEHPTFTSQY is a linear peptidic epitope (epitope ID75718) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
HCMV pp65 417 – 426 (HLA-B*07:02) ( TPRVTGGGAM )
Antigen Peptide CMV pp65 - HLA-B*07:02 (TPRVTGGGAM) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. CMV pp65 (415-429) (HLA-B7) is a CEF control peptide that is derived from the Cytomegalovirus (CMV). CMV is capable of infecting a wide range of human cell types, where the body’s primary immune response to CMV is innate, and relies on inflammatory cytokines and costimulatory molecules in order to control the spread of the virus. CMV pp65 (415-429) (HLA-B7) is defined as a CEF control peptide due to its antigenic properties. Clinically, these peptides are suitable epitopes for CD8+ T cells and can be used to stimulate the release of IFNg. HLA-B7 refers to the cell HLA type that this peptide acts on.

From €133.20*
Details
Tip
HCMV pp65 495-503 (HLA-A*02:01) ( NLVPMVATV )
Linear peptidic epitope (NLVPMVATV; epitope ID44920) for the stimulation of human CMV-specific CD8+ T-cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The synthesized peptide is presented by the MHC class I HLA-A*0201 allele. NLVPMVATV is part of the 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). 

From €105.00*
Details
HCMV pp65 512-521 (HLA-B*44:02) ( EFFWDANDIY )
EFFWDANDIY is a linear peptidic epitope (epitope ID11995) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays

From €105.00*
Details
Tip
HCMVA pp65 Peptide Pool
Peptide Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) (UniProtKB - P06725) of Human cytomegalovirus (HHV-5). Frequently used as positive control. One unit allows the stimulation of 2,5 x 108 cells. You can find applications and references in our blog: FACS analysis showed: CMV-specific T cells respond to leukemia antigen >

€245.70*
This website uses cookies to ensure the best experience possible. More information...